Effect of Statins on Fasting Plasma Glucose in Diabetic and Nondiabetic Patients
The DOI matches its Crossref record; 19 of the 20 references it cites were found in a registry or an index.
Abstract
Background: The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors (statins) reduce serum cholesterol level and cardiovascular morbidity and mortality. However, the effect of statins on glucose metabolism is unclear. Some studies have suggested that statins may cause hyperglycemia by increasing calcium concentration in the islet cells leading to decrease in insulin release or by decreasing GLUT 4-mediated peripheral glucose uptake. Methods: We analyzed the data in 345,417 patients (mean age 61 ± 15 years, 94% males, 6% diabetic, 20% statin users) from the Veterans Affairs VISN 16 database. We studied change in fasting plasma glucose (FPG) in this population over a mean time of 2 years between the first available measurement and the last measurement form the most recent recorded visit. Data were limited to patients who had 2 FPG measurements. Diagnosis of diabetes had to be present before the first FPG measurement. Results: Among patients without diabetes, FPG increased with statin use from 98 mg/dL to 105 mg/dL, and among nonstatin users, FPG increased from 97 mg/dL to 101 mg/dL (increase in FPG with statin use P < 0.0001). Among patients with diabetes, FPG increased with statin use from 102 mg/dL to 141 mg/dL, and among nonstatin users, FPG increased from 100 mg/dL to 129 mg/dL (increase in FPG with statin use; P < 0.0001). After adjustment for age and use of aspirin, β-blockers, and angiotensin-converting enzyme inhibitors, the change in FPG in nondiabetic statin users was 7 mg/dL (vs 5 mg/dL in nonstatin users, P < 0.0001) and for diabetic statin users it was 39 mg/dL (vs 32 in nonstatin users, P < 0.0001). Conclusions: Statin use is associated with a rise of FPG in patients with and without diabetes. This relationship between statin use and rise in FPG is independent of age and use of aspirin, β-blockers, and angiotensin-converting enzyme inhibitors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“an elevation of liver enzymes, hyperglycaemia [53], new onset of diabetes mellitus type 2 [54] and proteinuria.”
From Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention (2023) · cites this paper as [53]
Citations
Cites
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
Sever, P. S., Dahlöf, B., Poulter, N. R., Wedel, H., Beevers, G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12948-0 · Cited by 3,782
Colhoun, H. M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., W Neil, H. A., Livingstone, S. J., Thomason, M. J., Mackness, M. I., Charlton-Menys, V., & Fuller, J. H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16895-5 · Cited by 3,755
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641
Tuomilehto, J., Vidgren, G., Toivanen, L., Tuomilehto-Wolf, E., Kohtamaki, K., Stengård, J., Zimmet, P., Mackay, I. R., Rowley, M., & Koskela, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92521-6 · Cited by 1,692
Research works printed but not linked: 7
- Scandinavian Simvastatin Survival Study Group, 1994, Lancet, 344, 1383
- Collins R, 2003, Lancet, 361, 2005
- Colhoun HM, 2004, Lancet, 9435, 685
- Sabatine MS, 2004, Circulation, 110, S834
- Nakata M, 2006, Diabetologia, 49, 1881
- Sever PS, 2003, Lancet, 361, 1149
- Levitan EB, Arch Intern Med, 2147
Cited by
Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management
Chaudhury, A., Duvoor, C., Reddy Dendi, V. S., Kraleti, S., Chada, A., Ravilla, R., Marco, A., Shekhawat, N. S., Montales, M. T., Kuriakose, K., et al. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00006 · Cited by 1,500
“Nutr Metab Cardiovasc Dis (2010) 20(5):366–75.”
BackgroundPharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer
Gazzerro, P., Proto, M. C., Gangemi, G., Malfitano, A. M., Ciaglia, E., Pisanti, S., Santoro, A., Laezza, C., & Bifulco, M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004994 · Cited by 457
Cederberg, H., Stančáková, A., Yaluri, N., Modi, S., Kuusisto, J., & Laakso, M. (2015) · Diabetologia · doi:10.1007/s00125-015-3528-5 · Cited by 316
Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism
Caparrós-Martín, J. A., Lareu, R. R., Ramsay, J. P., Peplies, J., Reen, F. J., Headlam, H. A., Ward, N. C., Croft, K. D., Newsholme, P., Hughes, J. D., et al. (2017) · Microbiome · doi:10.1186/s40168-017-0312-4 · Cited by 212
Gutierrez, M. J., Rosenberg, N. L., MacDougall, D. E., Hanselman, J. C., Margulies, J. R., Strange, P., Milad, M. A., McBride, S. J., & Newton, R. S. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.302677 · Cited by 170
The Controversies of Statin Therapy
Jukema, J. W., Cannon, C. P., de Craen, A. J. M., Westendorp, R. G. J., & Trompet, S. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.007 · Cited by 168
Mansi, I. A., Chansard, M., Lingvay, I., Zhang, S., Halm, E. A., & Alvarez, C. A. (2021) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2021.5714 · Cited by 144
Statins, Risk of Diabetes, and Implications on Outcomes in the General Population
Wang, K.-L., Liu, C., Chao, T., Huang, C.-M., Wu, C., Chen, S., Chen, T., Lin, S., & Chiang, C. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.05.019 · Cited by 145
Nielsen, S. F., & Nordestgaard, B. G. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70173-1 · Cited by 125
Sampson, U. K., Linton, M. F., & Fazio, S. (2011) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283470359 · Cited by 116
KONES, R. J. (2010) · Drug Design Development and Therapy · doi:10.2147/dddt.s10812 · Cited by 141
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
Michaeli, D. T., Michaeli, J. C., Albers, S., Boch, T., & Michaeli, T. (2023) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-023-00594-5 · Cited by 109
“The most clinically significant adverse effects of statin therapy are muscle-associated symptoms including myopathy (11 per 100,000 patient years) up to rhabdomyolysis (3 per 100,000 patient years) [52], an elevation of liver enzymes, hyperglycaemia [53], new onset of Name MoA RoA LDL-C TG MACE Type”
BackgroundYe, Y., Liu, X., Wu, N., Han, Y., Wang, J., Yu, Y., & Chen, Q. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.653887 · Cited by 109
Tenenbaum, A., & Fisman, E. Z. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-140 · Cited by 107
Regulation of hepatic energy metabolism by the nuclear receptor PXR
Hakkola, J., Rysä, J., & Hukkanen, J. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.03.012 · Cited by 116
Statins are diabetogenic – Myth or reality?
Sattar, N. A., & Taskinen, M. (2012) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2012.06.001 · Cited by 117
Statins and Risk of New-Onset Diabetes Mellitus
Shah, R. V., & Goldfine, A. B. (2012) · Circulation · doi:10.1161/circulationaha.112.122135 · Cited by 106
Gumprecht, J., Gosho, M., Budinski, D., & Hounslow, N. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01477.x · Cited by 81
Mansi, I. A., Frei, C. R., Wang, C.-P., & Mortensen, E. M. (2015) · Journal of General Internal Medicine · doi:10.1007/s11606-015-3335-1 · Cited by 85
Gotoh, S., & Negishi, M. (2015) · Scientific Reports · doi:10.1038/srep14076 · Cited by 71
Wang, H. J., Park, J. Y., Kwon, O., Choe, E. Y., Kim, C. H., Hur, K. Y., Lee, M., Yun, M., Soo, B., Kim, Y., et al. (2015) · Autophagy · doi:10.1080/15548627.2015.1091139 · Cited by 67
Zafrir, B., & Jain, M. (2014) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-014-6534-9 · Cited by 57
Nuclear receptor phosphorylation in xenobiotic signal transduction
Negishi, M., Kobayashi, K., Sakuma, T., & Sueyoshi, T. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.007933 · Cited by 39
Ling, Z., Shu, N., Xu, P., Wang, F., Zhong, Z., Sun, B., Li, F., Zhang, M., Zhao, K., Tang, X., et al. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.11.023 · Cited by 52
Clinical usefulness of Glycated Albumin in the diagnosis of diabetes: Results from an Italian study
Bellia, C., Zaninotto, M., Cosma, C., Agnello, L., Bivona, G., Marinova, M., Sasso, B. L., Plebani, M., & Ciaccio, M. (2018) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2018.02.017 · Cited by 48
Statins impair glucose uptake in human cells
Nowis, D., Malenda, A., Furs, K., Oleszczak, B., Sadowski, R., Chlebowska, J., Firczuk, M., Bujnicki, J. M., Staruch, A. D., Zagozdzon, R., et al. (2014) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2014-000017 · Cited by 45
Management of dyslipidemia in the elderly population
Gobal, F. A., & Mehta, J. L. (2010) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944710385048 · Cited by 61
Self-citationStatins and the potential for higher diabetes mellitus risk
Yandrapalli, S., Malik, A. H., Guber, K., Rochlani, Y. M., Pemmasani, G., Jasti, M., & Aronow, W. S. (2019) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2019.1659133 · Cited by 46
Ko, D. T., Wijeysundera, H. C., Jackevicius, C. A., Yousef, A., Wang, J., & Tu, J. V. (2013) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.111.000015 · Cited by 43
Statins and the brain: New perspective for old drugs
Ling, Q., & Tejada-Simon, M. V. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.11.013 · Cited by 43
Associations of statin use with glycaemic traits and incident type 2 diabetes
Ahmadizar, F., Ochoa‐Rosales, C., Glisic, M., Franco, O. H., Muka, T., & Stricker, B. H. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13898 · Cited by 38
Statin Use Is Associated With Incident Diabetes Mellitus Among Patients in the HIV Outpatient Study
Lichtenstein, K. A., Hart, R. L. D., Wood, K. C., Bozzette, S. A., Buchacz, K. A., & Brooks, J. T. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000581 · Cited by 36
Antidepressant-like effect of simvastatin in diabetic rats
ElBatsh, M. M. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2014-0560 · Cited by 34
Gotoh, S., & Negishi, M. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.209379 · Cited by 33
Pitavastatin: A Review of its Use in the Management of Hypercholesterolaemia or Mixed Dyslipidaemia
Duggan, S. T. (2012) · Drugs · doi:10.2165/11207180-000000000-00000 · Cited by 33
The Effect of Simvastatin on Glucose Homeostasis in Streptozotocin Induced Type 2 Diabetic Rats
Wang, L., Duan, G., Lu, Y., Pang, S., Huang, X., Jiang, Q., & Dang, N. (2013) · Journal of Diabetes Research · doi:10.1155/2013/274986 · Cited by 32
Sun, B., Zhong, Z., Wang, F., Xu, J., Xu, F., Kong, W., Ling, Z., Shu, N., Li, Y., Wu, T., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.01.021 · Cited by 33
Statin therapy on glycaemic control in type 2 diabetes: a meta-analysis
Zhou, Y., Yuan, Y., Cai, R.-R., Huang, Y., Xia, W.-Q., Yang, Y., Wang, P., Wei, Q., & Wang, S.-H. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.810210 · Cited by 33
Statins and New-Onset Diabetes
Barylski, M., Nikolić, D., Banach, M., Toth, P. P., Montalto, G., & Rizzo, M. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660678 · Cited by 30
Orlando, P., Chellan, N., Louw, J., Tiano, L., Cirilli, I., Dludla, P. V., Joubert, E., & Muller, C. J. F. (2019) · Molecules · doi:10.3390/molecules24091713 · Cited by 33
Statin-Associated Incident Diabetes: A Literature Review
Park, Z. H., Juska, A., Dyakov, D., & Patel, R. V. (2014) · The Consultant Pharmacist · doi:10.4140/tcp.n.2014.317 · Cited by 33
Use of antidepressants and statins and short-term risk of new-onset diabetes among high risk adults
Bhattacharya, R., Ajmera, M., Bhattacharjee, S., & Sambamoorthi, U. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.04.016 · Cited by 28
Medical Management of Dyslipidemia for Secondary Stroke Prevention: Narrative Review
Chang, Y., Eom, S., Kim, M.-J., & Song, T. (2023) · Medicina · doi:10.3390/medicina59040776 · Cited by 31
Use of Statins and the Risk of Incident Diabetes: A Retrospective Cohort Study
Olotu, B., Shepherd, M. D., Novak, S., Lawson, K. A., Wilson, J. P., Richards, K. M., & Rasu, R. S. (2016) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-016-0176-1 · Cited by 27
Statin therapy is not warranted for a person with high LDL-cholesterol on a low-carbohydrate diet
Diamond, D. M., Bikman, B. T., & Mason, P. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000764 · Cited by 27
Balancing Primary Prevention and Statin-Induced Diabetes Mellitus Prevention
Rochlani, Y. M., Kattoor, A. J., Pothineni, N. V. K., Palagiri, R. D. R., Romeo, F., & Mehta, J. L. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.06.054 · Cited by 28
Self-citationSahebkar, A. (2013) · Metabolism · doi:10.1016/j.metabol.2013.08.017 · Cited by 21
Statins and Higher Diabetes Mellitus Risk: Incidence, Proposed Mechanisms, and Clinical Implications
Guber, K., Pemmasani, G., Malik, A. H., Aronow, W. S., Yandrapalli, S., & Frishman, W. H. (2020) · Cardiology in Review · doi:10.1097/crd.0000000000000348 · Cited by 23
Li, H., Lin, H., Zhao, H.-Y., Yang, X., Cheng, Y., Shen, P., & Zhan, S. (2018) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s158850 · Cited by 23
Statins may increase diabetes, but benefit still outweighs risk
Hoogwerf, B. J. (2023) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.90a.22069 · Cited by 29
Cholesterol-lowering therapy and cell membranes. Stable plaque at the expense of unstable membranes?
Wainwright, G., Mascitelli, L., & Goldstein, L. B. (2009) · Cited by 26
Rautio, N., Jokelainen, J. J., Oksa, H. H., Saaristo, T., Peltonen, M., Vanhala, M. J., Puolijoki, H., Moilanen, L., Tuomilehto, J. O., Keinanen-Kiukaanniemi, S. M., et al. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001472 · Cited by 19
Long-Term Outcomes of Short-Term Statin Use in Healthy Adults: A Retrospective Cohort Study
Mansi, I. A., English, J. L., Zhang, S., Mortensen, E. M., & Halm, E. A. (2016) · Drug Safety · doi:10.1007/s40264-016-0412-2 · Cited by 18
The Application of the LDL Principle
Schade, D. S., Cavanaugh, B., Ramo, B. W., & Eaton, R. P. (2016) · World Journal of Cardiovascular Diseases · doi:10.4236/wjcd.2016.65012 · Cited by 16
Jensen, M. T., Andersen, H. U., Rossing, P. R., & Jensen, J. S. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.10.022 · Cited by 18
Risk and Benefits of Statins in Glucose Control Management of Type II Diabetes
Sunjaya, A. F., Halim, S., Ferdinal, F., & Sunjaya, A. P. (2016) · International Journal of Angiology · doi:10.1055/s-0036-1572523 · Cited by 17
Statins: Rationale, Mode of Action, and Side Effects
Sultan, S., D'Souza, A., Zabetakis, I., Lordan, R., Τσούπρας, Α., Kavanagh, E. P., & Hynes, N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813792-5.00006-9 · Cited by 25
The Ugly Side of Statins. Systemic Appraisal of the Contemporary Un-Known Unknowns
Sultan, S., & Hynes, N. (2013) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2013.33025 · Cited by 18
The Role of Xenobiotic Receptors on Hepatic Glycolipid Metabolism
Chen, K., Zhong, J., Hu, L., Li, R., Du, Q., Cai, J., Li, Y., Gao, Y., Cui, X., Yang, X., et al. (2018) · Current Drug Metabolism · doi:10.2174/1389200219666180918152241 · Cited by 14
Huri, H. Z., Hui, D. L. Y., & Ahmad, W. A. W. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s87294 · Cited by 17
Yuan, L., Li‐Gao, R., Verhoeven, A., van Eyk, H. J., Bizino, M. B., Rensen, P. C. N., Giera, M. A., Jazet, I. M., Lamb, H. J., Rabelink, T. J., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15118 · Cited by 17
ncBAF enhances PXR-mediated transcriptional activation in the human and mouse liver
Kurosawa, K., Nakano, M., Yokoseki, I., Nagaoka, M., Takemoto, S., Sakai, Y., Kobayashi, K., Kazuki, Y., Fukami, T., & Nakajima, M. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115733 · Cited by 14
Simvastatin profoundly impairs energy metabolism in primary human muscle cells
Mäkinen, S., Datta, N., Nguyen, Y. H., Kyrylenko, P., Laakso, M., & Koistinen, H. A. (2020) · Endocrine Connections · doi:10.1530/ec-20-0444 · Cited by 12
Pharmacovigilance Working Party (PhVWP)
Wharf, C., London, E., O’Malley, K., & Terrace, E. (2011) · Cited by 12
Statin therapy and new-onset diabetes: an attempt at recommendations
Banach, M., & Mikhailidis, D. P. (2013) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.13.16 · Cited by 12
Mansi, I. A., Frei, C. R., Halm, E. A., & Mortensen, E. M. (2017) · Journal of Investigative Medicine · doi:10.1136/jim-2016-000218 · Cited by 12
Baul, P. B., Deepak, A. D., Kakkar, M., & Modi, S. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.07.020 · Cited by 11
Toth, P. P., Catapano, A. L., Farnier, M., Foody, J. M., Tomassini, J. E., Jensen, E. H., Polis, A. B., Hanson, M. E., Musliner, T. A., & Tershakovec, A. M. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.08.071 · Cited by 9
A New American Amblyopone, With Notes on the Genus (Hymenoptera:Formicidae)
Brown, W. L. (1949) · Psyche A Journal of Entomology · doi:10.1155/1949/67378 · Cited by 9
Kang, D. O., Seo, H. S., Choi, B. G., Lee, E. M., Kim, J. P., Lee, S. K., Im, S. I., Na, J. O., Choi, C. U., Lim, H. E., et al. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.10.164 · Cited by 10
Statin-Induced Diabetes: Will It Change Clinical Practice?
Belalcazar, L. M., Raghavan, V. A., & Ballantyne, C. M. (2009) · Diabetes Care · doi:10.2337/dc09-1277 · Cited by 11
Varga, T. V., Xu, T., Kivimäki, M., Mehta, A. J., Rugulies, R., & Rod, N. H. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab704 · Cited by 8
Pintó, X., & Formiga, F. (2012) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2012.05.005 · Cited by 10
Khanimov, I., Segal, G., Wainstein, J., Boaz, M., Shimonov, M., & Leibovitz, E. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.04.050 · Cited by 8
Dautović, E., Rustemović-Čorbić, M., Srabović, N., Softič, A., Smajlović, A., Husejnović, M. Š., Hatkić, A., & Halilčević, D. (2023) · Advances in Medical Sciences · doi:10.1016/j.advms.2023.07.002 · Cited by 10
Mansi, I. A., Chansard, M., Lingvay, I., Zhang, S., Halm, E. A., & Álvarez, C. A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269982 · Cited by 9
Simvastatin Impairs Glucose Homeostasis in Mice Depending on PGC-1α Skeletal Muscle Expression
Panajatovic, M. V., Singh, F., Krähenbühl, S., & Bouitbir, J. (2020) · Biomedicines · doi:10.3390/biomedicines8090351 · Cited by 7
Jaisamut, P., Tohlang, C., Wanna, S., Thanakun, A., Srisuwan, T., Limsuwan, S., Rattanachai, W., Suwannachot, J., & Chusri, S. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/2530266 · Cited by 7
Wu, Z., Chen, S., Tao, X., Liu, H., Sun, P., Richards, M., Tan, H. C., Yu, Y., Yang, Q., Wu, S., et al. (2024) · Clinical Research in Cardiology · doi:10.1007/s00392-024-02381-x · Cited by 7
Schade, D. S., Obenshain, S. S., Hickey, M., Febbo, J., Wann, S., & Eaton, R. P. (2022) · World Journal of Cardiovascular Diseases · doi:10.4236/wjcd.2022.126032 · Cited by 6
Valero‐Muñoz, M., Martín‐Fernández, B., Ballesteros, S., Cachofeiro, V., Lahera, V., & Heras, N. D. L. (2014) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2013.12.005 · Cited by 6
Song, B., Sun, L., Qin, X., Fei, J., Yu, Q., Chang, X., He, Y., Liu, Y., Shi, M., Guo, D., et al. (2025) · Hypertension · doi:10.1161/hypertensionaha.124.23829 · Cited by 6
Cardiovascular disease: primary prevention, disease modulation and regenerative therapy
Sultan, S., & Hynes, N. (2012) · Vascular · doi:10.1258/vasc.2012.ra0062 · Cited by 5
Diamond, D. M., & Leaverton, P. E. (2023) · Cureus · doi:10.7759/cureus.38391 · Cited by 10
Mechanistic pathway of herbs in the amelioration of NAFLD: A systematic review
Jayanti, N. E., Said, R. M., Jofrry, S. M., & Choo, C. (2024) · World Academy of Sciences Journal · doi:10.3892/wasj.2024.245 · Cited by 7
Statins: An Update on Clinical Issues and Selected Adverse Effects
Gulum, A. H., & Hume, A. L. (2015) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2014.09.004 · Cited by 5
Management of Diabetes Mellitus
Jenkins, A. J., SCOTT, E. S., Fulcher, J., Kilov, G., & Januszewski, A. S. (2018) · Contemporary cardiology · doi:10.1007/978-3-319-97622-8_7 · Cited by 6
Does intensive cholesterol lowering increase the risk of diabetes?
Mascitelli, L., Pezzetta, F., & Goldstein, M. R. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02213.x · Cited by 5
STATINS AND THE RISK OF DIABETES MELLITUS
Drapkina, O. M. (2013) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2013-9-4-444-447 · Cited by 4
Statins, Glycemia, and Diabetes Mellitus: Another Point of View
Štulc, T., & Češka, R. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0458-5 · Cited by 4
Vu, A., Kosmiski, L. A., Beitelshees, A. L., Prigeon, R. L., Sidhom, M. S., Bredbeck, B. C., Predhomme, J. A., Deininger, K. M., & Aquilante, C. L. (2016) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1713 · Cited by 4
Association of Statins and Diabetes Mellitus
Hagedorn, J. M., & Arora, R. R. (2010) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3181c4f77e · Cited by 4
Statins and Altered Glucose Metabolism
Mehta, J. L. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.03.062 · Cited by 4
Self-citationStatin-induced diabetes: too sweet a deal?
Turgeon, R. D., & Allan, G. M. (2013) · Europe PMC (PubMed Central) · Cited by 3
van Bruggen, F. H., & Diamond, D. M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14103569 · Cited by 4
Predictors of the effectiveness of insulin pumps in patients with type 1 diabetes mellitus
Neves, J. C., Neves, J. S., Neves, C., & Carvalho, D. M. (2021) · Endocrine · doi:10.1007/s12020-021-02837-4 · Cited by 4
Pacella, D., Lembo, M., Trimarco, V., Izzo, A., Manzi, M. V., Jankauskas, S. S., Forzano, I., Gallo, P., Spinelli, A. M., Morisco, C., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02920-4 · Cited by 4
Modest effect of statins on fasting glucose in a longitudinal electronic health record based cohort
Haldar, T., Oni‐Orisan, A., Hoffmann, T. J., Schaefer, C. A., Iribarren, C., Krauss, R. M., Medina, M. W., & RISCH, N. J. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01566-w · Cited by 2
Nalini, R., Ramya, J. E., & Karthick, R. (2022) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_943_20 · Cited by 2
Statin use in setting of HIV infection
Lichtenstein, K. A. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-s2-s10 · Cited by 2
Metadata
- Authors
- Sukhija, R., Prayaga, S., Marashdeh, M., Bursac, Z., Kakar, P., Bansal, D., Sachdeva, R., Kesan, S. H., & Mehta, J. L.
- Affiliations
- Division of Cardiovascular Medicine, Little Rock
- Central Arkansas Veterans Healthcare System (US)
- University of Arkansas for Medical Sciences (US)
- Venue
- Journal of Investigative Medicine
- Publisher
- SAGE Publications
- Published
- 2009-03
- Volume
- 57
- Issue
- 3
- Pages
- 495-499
- ISSN
- 1081-5589 (ISSN-L)
- 1708-8267
- OpenAlex
- W121422619
- Cited by
- 126
- References
- 20
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 8 · 2022: 10 · 2021: 5 · 2020: 5 · 2019: 5 · 2018: 6 · 2017: 7 · 2016: 10 · 2015: 11 · 2014: 12 · 2013: 12 · 2012: 15
- FWCI
- 9.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Investigative Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- statins, fasting blood glucose, hyperglycemia, diabetes mellitus, glucose metabolism, veterans, insulin secretion, adverse drug reactions
- MeSH terms
- Aged, Blood Glucose, Diabetes Mellitus, Fasting, Food Deprivation, Humans, Hypertension, Male, Middle Aged, United States, Veterans, Databases, Factual, Treatment Outcome, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Diabetes Complications, Dyslipidemias
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.